RecruitingPhase 2NCT07446322
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Sponsor: Oncolytics Biotech
Post Falls, ID · +16 more sites
2 recruiting colorectal cancer studies with a site in Post Falls, ID.
Sponsor: Oncolytics Biotech
Post Falls, ID · +16 more sites
Sponsor: Alliance for Clinical Trials in Oncology
Boise, ID · Caldwell, ID · Coeur d'Alene, ID · +357 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.